Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 3/30/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. B. Taylor Thompson

Wrong Dr. B. Taylor Thompson?

Field Applications Specialist

Phone: (800) ***-****  
Email: b***@***.com
Local Address:  Boston , Massachusetts , United States
Promega Corporation
2800 Woods Hollow Road
Madison , Wisconsin 53711
United States

Company Description: Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company’s 2,000 products enable...   more

Employment History

Board Memberships and Affiliations


  • M.D.
  • MD
31 Total References
Web References
Faculty | Critical Care Canada, 5 Dec 2015 [cached]
B. Taylor Thompson (Boston, USA)
ATS 365 - eDailies 2010, 14 Sept 2013 [cached]
B. Taylor Thompson, M.D., who is associate professor of medicine at Harvard Medical School and director of the Medical Intensive Care Unit at Massachusetts General Hospital in Boston, will present "2009 H1N1-Associated Critical Illness in Adults.
B. Taylor ... [cached]
B. Taylor Thompson
Dr. B. Taylor Thompson
Dr. Thompson is a Professor of Medicine at Harvard Medical School. He is the director of Pulmonary and Critical Care Translational Research at Massachusetts General Hospital and the Medical Director of the NHLBI-funded PETAL Clinical Coordinating Center. His primary research interests are clinical trials of new therapies for ARDS and sepsis. Dr. Thompson has been a practicing intensivist and educator at MGH and Harvard Medical School for over 30 years and has published over 160 peer reviewed manuscripts.
Boyd Taylor Thompson, ..., 26 July 2013 [cached]
Boyd Taylor Thompson, M.D.
Professor of Medicine at Harvard Medical School, Director of Medical ICU at Massachusetts General Hospital
The findings of the cancelled study ..., 12 Dec 2011 [cached]
The findings of the cancelled study may be sufficient to change treatment of patients with ARDS, Dr. B. Taylor Thompson, of Massachusetts General Hospital and Harvard Medical School, wrote in an accompanying editorial. "[Beta-2] agonist treatment in patients with ARDS should be limited to the treatment of clinically important reversible airway obstruction and should not be part of routine care," Thompson recommended.
Other People with the name "Thompson":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.